Patent ID: 8377640

Claim:
A method for aiding in a diagnosis of a neurological condition in a human subject, wherein said neurological condition is selected from the group consisting of: Alzheimer's disease; incipient Alzheimer's disease; possible Alzheimer's disease; and Alzheimer's disease associated with evidence of other type of dementia; wherein said method comprises the steps of: (A) determining the effectiveness of the G1/S cell cycle checkpoint exhibited by a non-neuronal and non-actively malignant cell of said subject; and (B) comparing said determined G1/S cell cycle checkpoint effectiveness with the G1/S cell cycle checkpoint effectiveness exhibited by a non-neuronal reference cell of a healthy individual or of an individual having said neurological condition to thereby determine whether a defect exists in the effectiveness of G1/S cell cycle checkpoint exhibited by said subject, wherein said defect reduces the effectiveness of G1/S checkpoint control; whereby the presence of said defect is indicative of the neurological condition in said subject and thereby aids in the diagnosis of said neurological condition.